EXHIBIT 31.1
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized
ONCOLIN THERAPEUTICS, INC.
By: /s/ J. Leonard Ivins
J. Leonard Ivins, Chief Executive Officer
Date: May 19, 2010, 2010
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature | Title | Date |
/s/ J. Leonard Ivins | Chief Executive Officer and | May 19, 2010 |
J. Leonard Ivins | Chairman of the Board |